Clinical trial
The Akloma Tinnitus Patch in Patients With Manifested Tinnitus (the Aktin Study)
NCT01226108 is registered in ClinicalTrials.gov with Akloma Bioscience AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Akloma Tinnitus Patch in Patients With Manifested Tinnitus (the Aktin Study)
- Lead sponsor
- Akloma Bioscience AB
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- Not reported
- Enrollment
- 16 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.